262 related articles for article (PubMed ID: 1623766)
1. The effects of pharmaceutical firm enticements on physician prescribing patterns. There's no such thing as a free lunch.
Orlowski JP; Wateska L
Chest; 1992 Jul; 102(1):270-3. PubMed ID: 1623766
[TBL] [Abstract][Full Text] [Related]
2. Interactions between physicians and the pharmaceutical industry: what does the literature say?
Lexchin J
CMAJ; 1993 Nov; 149(10):1401-7. PubMed ID: 8221424
[TBL] [Abstract][Full Text] [Related]
3. Ethical relationships between drug companies and the medical profession.
Rosner F
Chest; 1992 Jul; 102(1):266-9. PubMed ID: 1623765
[No Abstract] [Full Text] [Related]
4. Pharmaceutical Industry-Sponsored Meals and Physician Prescribing Patterns for Medicare Beneficiaries.
DeJong C; Aguilar T; Tseng CW; Lin GA; Boscardin WJ; Dudley RA
JAMA Intern Med; 2016 Aug; 176(8):1114-1122. PubMed ID: 27322350
[TBL] [Abstract][Full Text] [Related]
5. Association between industry payments and prescribing costly medications: an observational study using open payments and medicare part D data.
Sharma M; Vadhariya A; Johnson ML; Marcum ZA; Holmes HM
BMC Health Serv Res; 2018 Apr; 18(1):236. PubMed ID: 29609611
[TBL] [Abstract][Full Text] [Related]
6. Association of Industry Payments to Physicians With the Prescribing of Brand-name Statins in Massachusetts.
Yeh JS; Franklin JM; Avorn J; Landon J; Kesselheim AS
JAMA Intern Med; 2016 Jun; 176(6):763-8. PubMed ID: 27159336
[TBL] [Abstract][Full Text] [Related]
7. The drug industry and medical practice--the case of menopausal hormone therapy in Estonia.
Hemminki E; Karttunen T; Hovi SL; Karro H
Soc Sci Med; 2004 Jan; 58(1):89-97. PubMed ID: 14572923
[TBL] [Abstract][Full Text] [Related]
8. The Association of Industry Payments to Physicians with Prescription of Brand-Name Intranasal Corticosteroids.
Morse E; Fujiwara RJT; Mehra S
Otolaryngol Head Neck Surg; 2018 Sep; 159(3):442-448. PubMed ID: 29865931
[TBL] [Abstract][Full Text] [Related]
9. Impact of pharmaceutical sales representatives on physician antibiotic prescribing.
Cleary JD
J Pharm Technol; 1992; 8(1):27-9. PubMed ID: 10118197
[TBL] [Abstract][Full Text] [Related]
10. Changes in drug prescribing patterns related to commercial company funding of continuing medical education.
Bowman MA; Pearle DL
J Contin Educ Health Prof; 1988; 8(1):13-20. PubMed ID: 10294441
[TBL] [Abstract][Full Text] [Related]
11. Effects of Physician-directed Pharmaceutical Promotion on Prescription Behaviors: Longitudinal Evidence.
Datta A; Dave D
Health Econ; 2017 Apr; 26(4):450-468. PubMed ID: 26893065
[TBL] [Abstract][Full Text] [Related]
12. A physician survey of the effect of drug sample availability on physicians' behavior.
Chew LD; O'Young TS; Hazlet TK; Bradley KA; Maynard C; Lessler DS
J Gen Intern Med; 2000 Jul; 15(7):478-83. PubMed ID: 10940134
[TBL] [Abstract][Full Text] [Related]
13. Counter sampling combined with medical provider education: do they alter prescribing behavior?
Erramouspe J; Bailey JM; Cleveland KW; Casperson K; Hunt TL; Cady PS
Consult Pharm; 2006 Aug; 21(8):636-42. PubMed ID: 17076590
[TBL] [Abstract][Full Text] [Related]
14. Quantifying the physician contribution to managed care pharmacy expenses: a random effects approach.
Cowen ME; Strawderman RL
Med Care; 2002 Aug; 40(8):650-61. PubMed ID: 12187179
[TBL] [Abstract][Full Text] [Related]
15. Experts' agency problems: evidence from the prescription drug market in Japan.
Iizuka T
Rand J Econ; 2007; 38(3):844-62. PubMed ID: 18478669
[TBL] [Abstract][Full Text] [Related]
16. Effect of physician payment disclosure laws on prescribing.
Pham-Kanter G; Alexander GC; Nair K
Arch Intern Med; 2012 May; 172(10):819-21. PubMed ID: 22636826
[No Abstract] [Full Text] [Related]
17. Reforming pharmaceutical industry-physician financial relationships: lessons from the United States, France, and Japan.
Rodwin MA
J Law Med Ethics; 2011; 39(4):662-70. PubMed ID: 22084852
[TBL] [Abstract][Full Text] [Related]
18. Drug advertising, continuing medical education, and physician prescribing: a historical review and reform proposal.
Rodwin MA
J Law Med Ethics; 2010; 38(4):807-15. PubMed ID: 21105944
[TBL] [Abstract][Full Text] [Related]
19. Pharmaceutical Industry Payments and Oncologists' Selection of Targeted Cancer Therapies in Medicare Beneficiaries.
Mitchell AP; Winn AN; Dusetzina SB
JAMA Intern Med; 2018 Jun; 178(6):854-856. PubMed ID: 29630687
[TBL] [Abstract][Full Text] [Related]
20. Patients' attitudes about gifts to physicians from pharmaceutical companies.
Blake RL; Early EK
J Am Board Fam Pract; 1995; 8(6):457-64. PubMed ID: 8585404
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
